{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:57:05Z","timestamp":1793383025634,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s43032-019-00106-4","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T14:02:41Z","timestamp":1581602561000},"page":"1074-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["YAP\/TAZ are Activated by Mechanical and Hormonal Stimuli in Myometrium and Exhibit Increased Baseline Activation in Uterine Fibroids"],"prefix":"10.1007","volume":"27","author":[{"given":"MacKenzie P.","family":"Purdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrick","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Haak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovanka","family":"Ravix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. S.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Tschumperlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"issue":"6","key":"106_CR1","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151(6):2433\u201342.","journal-title":"Endocrinology."},{"issue":"10","key":"106_CR2","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","volume":"124","author":"EA Stewart","year":"2017","unstructured":"Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501\u201312.","journal-title":"BJOG."},{"issue":"17","key":"106_CR3","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","volume":"372","author":"EA Stewart","year":"2015","unstructured":"Stewart EA. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646\u201355.","journal-title":"N Engl J Med"},{"issue":"10","key":"106_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/jwh.2013.4334","volume":"22","author":"EA Stewart","year":"2013","unstructured":"Stewart EA, Nicholson WK, Bradley L, Borah BJ. The burden of uterine fibroids for African-American women: results of a national survey. J Women\u2019s Health (Larchmt). 2013;22(10):807\u201316.","journal-title":"J Women\u2019s Health (Larchmt)"},{"issue":"5","key":"106_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jpsychores.2014.12.016","volume":"78","author":"MS Ghant","year":"2015","unstructured":"Ghant MS, Sengoba KS, Recht H, Cameron KA, Lawson AK, Marsh EE. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women\u2019s emotional and psychosocial health. J Psychosom Res. 2015;78(5):499\u2013503.","journal-title":"J Psychosom Res"},{"issue":"3","key":"106_CR6","doi-asserted-by":"publisher","first-page":"211 e211","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211 e211\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"5728","key":"106_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589\u201392.","journal-title":"Science."},{"issue":"50","key":"106_CR8","doi-asserted-by":"publisher","first-page":"19887","DOI":"10.1073\/pnas.0808188105","volume":"105","author":"SD Peddada","year":"2008","unstructured":"Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"106_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/molehr\/gat083","volume":"20","author":"SJ Holdsworth-Carson","year":"2014","unstructured":"Holdsworth-Carson SJ, Zaitseva M, Vollenhoven BJ, Rogers PA. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol Hum Reprod. 2014;20(3):250\u20139.","journal-title":"Mol Hum Reprod"},{"issue":"9","key":"106_CR10","doi-asserted-by":"publisher","first-page":"e75844","DOI":"10.1371\/journal.pone.0075844","volume":"8","author":"F Koohestani","year":"2013","unstructured":"Koohestani F, Braundmeier AG, Mahdian A, Seo J, Bi J, Nowak RA. Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells. PLoS One. 2013;8(9):e75844.","journal-title":"PLoS One"},{"issue":"3","key":"106_CR11","first-page":"900","volume":"79","author":"EA Stewart","year":"1994","unstructured":"Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 1994;79(3):900\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"106_CR12","doi-asserted-by":"publisher","first-page":"474 e471\u2013411","DOI":"10.1016\/j.ajog.2007.11.057","volume":"198","author":"R Rogers","year":"2008","unstructured":"Rogers R, Norian J, Malik M, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 2008;198(4):474 e471\u2013411.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"106_CR13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/cphy.c100016","volume":"1","author":"DJ Tschumperlin","year":"2011","unstructured":"Tschumperlin DJ. Mechanotransduction. Compr Physiol. 2011;1(2):1057\u201373.","journal-title":"Compr Physiol"},{"issue":"4","key":"106_CR14","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","volume":"35","author":"M Fang","year":"2014","unstructured":"Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumour Biol. 2014;35(4):2871\u201382.","journal-title":"Tumour Biol"},{"key":"106_CR15","doi-asserted-by":"publisher","first-page":"783289","DOI":"10.1155\/2014\/783289","volume":"2014","author":"PC Leppert","year":"2014","unstructured":"Leppert PC, Jayes FL, Segars JH. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int. 2014;2014:783289.","journal-title":"Obstet Gynecol Int"},{"key":"106_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2015.01.007","volume":"150","author":"V Sathish","year":"2015","unstructured":"Sathish V, Martin YN, Prakash YS. Sex steroid signaling: implications for lung diseases. Pharmacol Ther. 2015;150:94\u2013108.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"106_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1755-1536-6-20","volume":"6","author":"DL Clarke","year":"2013","unstructured":"Clarke DL, Carruthers AM, Mustelin T, Murray LA. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Fibrogenesis Tissue Repair. 2013;6(1):20.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"4","key":"106_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/humupd\/2.4.295","volume":"2","author":"EA Stewart","year":"1996","unstructured":"Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update. 1996;2(4):295\u2013306.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"106_CR19","doi-asserted-by":"publisher","first-page":"L628","DOI":"10.1152\/ajplung.00173.2017","volume":"313","author":"PB Dieffenbach","year":"2017","unstructured":"Dieffenbach PB, Haeger CM, Coronata AMF, Choi KM, Varelas X, Tschumperlin DJ, et al. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP\/TAZ-mediated repression of cyclooxygenase-2. Am J Physiol Lung Cell Mol Physiol. 2017;313(3):L628\u201347.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"1","key":"106_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1172\/JCI93561","volume":"128","author":"DJ Tschumperlin","year":"2018","unstructured":"Tschumperlin DJ, Ligresti G, Hilscher MB, Shah VH. Mechanosensing and fibrosis. J Clin Invest. 2018;128(1):74\u201384.","journal-title":"J Clin Invest"},{"issue":"3","key":"106_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/humrep\/dey384","volume":"34","author":"CL Mulder","year":"2019","unstructured":"Mulder CL, Eijkenboom LL, Beerendonk CCM, Braat DDM, Peek R. Enhancing the safety of ovarian cortex autotransplantation: cancer cells are purged completely from human ovarian tissue fragments by pharmacological inhibition of YAP\/TAZ oncoproteins. Hum Reprod. 2019;34(3):506\u201318.","journal-title":"Hum Reprod"},{"issue":"2","key":"106_CR22","first-page":"83","volume":"41","author":"JH Park","year":"2018","unstructured":"Park JH, Shin JE, Park HW. The role of Hippo pathway in cancer stem cell biology. Mol Cells. 2018;41(2):83\u201392.","journal-title":"Mol Cells"},{"issue":"4","key":"106_CR23","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: Hippo signaling and beyond. Physiol Rev. 2014;94(4):1287\u2013312.","journal-title":"Physiol Rev"},{"issue":"1","key":"106_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34(1):130\u201362.","journal-title":"Endocr Rev"},{"issue":"F1000 Faculty R","key":"106_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.12688\/f1000research.6189.1","volume":"4","author":"DK Taylor","year":"2015","unstructured":"Taylor DK, Holthouser K, Segars JH, Leppert PC. Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management. F1000Res. 2015;4(F1000 Faculty Rev):183.","journal-title":"F1000Res"},{"key":"106_CR26","first-page":"CD010770","volume":"4","author":"A Murji","year":"2017","unstructured":"Murji A, Whitaker L, Chow TL, Sobel ML. Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database Syst Rev. 2017;4:CD010770.","journal-title":"Cochrane Database Syst Rev"},{"key":"106_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1874325000903010014","volume":"3","author":"JR Rey","year":"2009","unstructured":"Rey JR, Cervino EV, Rentero ML, Crespo EC, Alvaro AO, Casillas M. Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice. Open Orthop J. 2009;3:14\u201321.","journal-title":"Open Orthop J"},{"key":"106_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","volume":"34","author":"FM Reis","year":"2016","unstructured":"Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13\u201324.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"106_CR29","doi-asserted-by":"publisher","first-page":"15321","DOI":"10.1038\/ncomms15321","volume":"8","author":"G Nardone","year":"2017","unstructured":"Nardone G, Oliver-De La Cruz J, Vrbsky J, et al. YAP regulates cell mechanics by controlling focal adhesion assembly. Nat Commun. 2017;8:15321.","journal-title":"Nat Commun"},{"issue":"20","key":"106_CR30","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1093\/nar\/22.20.4224","volume":"22","author":"T Thundat","year":"1994","unstructured":"Thundat T, Allison DP, Warmack RJ. Stretched DNA structures observed with atomic force microscopy. Nucleic Acids Res. 1994;22(20):4224\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"106_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0958-3947(02)00139-5","volume":"27","author":"DM Dimitriadis","year":"2002","unstructured":"Dimitriadis DM, Fallone BG. Compensators for intensity-modulated beams. Med Dosim. 2002;27(3):215\u201320.","journal-title":"Med Dosim"},{"issue":"6","key":"106_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00192-006-0214-7","volume":"18","author":"L Lei","year":"2007","unstructured":"Lei L, Song Y, Chen R. Biomechanical properties of prolapsed vaginal tissue in pre- and postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(6):603\u20137.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"1","key":"106_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.matbio.2011.09.001","volume":"31","author":"JM Norian","year":"2012","unstructured":"Norian JM, Owen CM, Taboas J, et al. Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biol. 2012;31(1):57\u201365.","journal-title":"Matrix Biol"},{"issue":"4","key":"106_CR34","doi-asserted-by":"publisher","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","volume":"308","author":"F Liu","year":"2015","unstructured":"Liu F, Lagares D, Choi KM, Stopfer L, Marinkovi\u0107 A, Vrbanac V, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344\u201357.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"106_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40169-018-0202-9","volume":"7","author":"O Dobrokhotov","year":"2018","unstructured":"Dobrokhotov O, Samsonov M, Sokabe M, Hirata H. Mechanoregulation and pathology of YAP\/TAZ via Hippo and non-Hippo mechanisms. Clin Transl Med. 2018;7(1):23.","journal-title":"Clin Transl Med"},{"issue":"12","key":"106_CR36","doi-asserted-by":"publisher","first-page":"6096","DOI":"10.1074\/jbc.M115.708313","volume":"291","author":"A Das","year":"2016","unstructured":"Das A, Fischer RS, Pan D, Waterman CM. YAP nuclear localization in the absence of cell-cell contact is mediated by a filamentous actin-dependent, myosin II-and phospho-YAP-independent pathway during extracellular matrix mechanosensing. J Biol Chem. 2016;291(12):6096\u2013110.","journal-title":"J Biol Chem"},{"issue":"4","key":"106_CR37","first-page":"479","volume":"40","author":"M Farber","year":"1972","unstructured":"Farber M, Conrad S, Heinrichs WL, Herrmann WL. Estradiol binding by fibroid tumors and normal myometrium. Obstet Gynecol. 1972;40(4):479\u201386.","journal-title":"Obstet Gynecol"},{"key":"106_CR38","first-page":"CD010854","volume":"3","author":"RM Moroni","year":"2015","unstructured":"Moroni RM, Martins WP, Ferriani RA, et al. Add-back therapy with GnRH analogues for uterine fibroids. Cochrane Database Syst Rev. 2015;3:CD010854.","journal-title":"Cochrane Database Syst Rev"},{"issue":"29","key":"106_CR39","doi-asserted-by":"publisher","first-page":"11930","DOI":"10.1073\/pnas.1103345108","volume":"108","author":"NG Kim","year":"2011","unstructured":"Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci U S A. 2011;108(29):11930\u20135.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43032-019-00106-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T13:03:37Z","timestamp":1665839017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43032-019-00106-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1007\/s43032-019-00106-4","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol has been approved by the Mayo Clinic IRB (17-003124). All patient information was de-identified.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Stewart reports personal fees from Bayer, personal fees from AbbVie, personal fees from Myovant, personal fees from UpToDate, personal fees from Med Learning Group, outside the submitted work; in addition, Dr. Stewart has a patent Methods and Compounds for Treatment of Abnormal Uterine Bleeding 6440445 issued.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}